Store lyophilized CJC-1295 in a freezer at -20C
A clinician-guided evaluation is the safer path
Despite the expanding use of anti-obesity medications (AOMs), sarcopenia and sarcopenic obesity (SO) remain major concerns in this population
As an illustration of the trial framework not as prescribing guidance the general approach observed involved: A low starting dose (2 mg once weekly) for the initial 4 weeks Incremental increases (for example, to 4 mg, 8 mg, and 12 mg) at approximately 4-weekly intervals, subject to individual tolerability Maintenance doses ranging from 4 mg to 12 mg once weekly across different trial arms These figures are provided solely to describe the research context
Manufactured according to premium peptide formulation standards
Common cardio exercises include dancing, running, swimming, brisk walking, aerobics, kickboxing, skiing, surfing, and bike riding